BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26214618)

  • 1. HIF-1α in colorectal carcinoma: review of the literature.
    Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
    J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
    Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
    Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.
    Yoshimura H; Dhar DK; Kohno H; Kubota H; Fujii T; Ueda S; Kinugasa S; Tachibana M; Nagasue N
    Clin Cancer Res; 2004 Dec; 10(24):8554-60. PubMed ID: 15623639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIF-1alpha expression and relationship involving tumor cell proliferation and angiogenesis in human breast carcinoma].
    Hao LS; Wang G; Qian K; Luo T; Li XJ; Wu XT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):60-3. PubMed ID: 17294729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer.
    Qiu Y; Zheng H; Sun LH; Peng K; Xiao WD; Yang H
    World J Gastroenterol; 2015 Dec; 21(48):13447-56. PubMed ID: 26730155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α.
    Hou P; Chen F; Yong H; Lin T; Li J; Pan Y; Jiang T; Li M; Chen Y; Song J; Zheng J; Bai J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):301. PubMed ID: 31291975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
    Kaidi A; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer.
    Wei TT; Lin YT; Tang SP; Luo CK; Tsai CT; Shun CT; Chen CC
    Oncogene; 2020 Jan; 39(2):414-427. PubMed ID: 31477841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
    Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma].
    Jiang CQ; Liu ZS; Qian Q; He YM; Yuan YF; Ai ZL
    Ai Zheng; 2003 Nov; 22(11):1170-4. PubMed ID: 14613646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer.
    Tuomisto A; García-Solano J; Sirniö P; Väyrynen J; Pérez-Guillermo M; Mäkinen MJ; Conesa-Zamora P
    Virchows Arch; 2016 Oct; 469(4):395-404. PubMed ID: 27421843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
    Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
    Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.